cheqfx
Advertisement · 728×90
‹ All stocks
RXST

RxSight

RXST · NASDAQ · Healthcare
$4.68
▼ $4.68 (-1.47%)
$4.68 $4.75 $4.83 $4.90 $4.68 Sep 26 Sep 30 Oct 04
Day range
$4.63 – $4.77
Year range
$4.48 – $13.22
Open
$4.75
Previous close
—
Market cap
$193.74M
Volume (24h)
$209.4K
Volume (52w)
$979.96K
Performance
7D
▲ 0.21%
1M
▼ -33.43%
3M
▼ -16.43%
6M
▼ -33.33%
1Y
▼ -45.33%
YTD
▼ -54.91%
3Y
▼ -81.99%
5Y
▼ -65.74%
All-time
▼ -70.75%
Key statistics
P/E ratio
-4.14
EPS (TTM)
$-1.13
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
41.4M
About RxSight

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.

Visit website
Country: United States of America
More in Healthcare